SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-23-009110
Filing Date
2023-02-08
Accepted
2023-02-08 06:05:21
Documents
1
Group Members
DANIEL B. ASHERMITCHELL P. KOPIN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea172850-13ga2intra_pharma.htm SC 13G/A 64641
  Complete submission text file 0001213900-23-009110.txt   66385
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Subject) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: SC 13G/A | Act: 34 | File No.: 005-91495 | Film No.: 23596931
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 245 PALM TRAIL DELRAY BEACH FL 33483
Business Address 245 PALM TRAIL DELRAY BEACH FL 33483 8475629030
INTRACOASTAL CAPITAL, LLC (Filed by) CIK: 0001646799 (see all company filings)

IRS No.: 320460881 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A